Imaging Endpoints Revenue and Competitors

Phoenix, AZ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Imaging Endpoints's estimated annual revenue is currently $46.2M per year.(i)
  • Imaging Endpoints's estimated revenue per employee is $201,000

Employee Data

  • Imaging Endpoints has 230 Employees.(i)
  • Imaging Endpoints grew their employee count by 5% last year.

Imaging Endpoints's People

NameTitleEmail/Phone
1
Chief Scientific OfficerReveal Email/Phone
2
Associate VPReveal Email/Phone
3
CEO, President and Board MemberReveal Email/Phone
4
Associate VP, FinanceReveal Email/Phone
5
VP Corporate DevelopmentReveal Email/Phone
6
VP, Data ManagementReveal Email/Phone
7
General CounselReveal Email/Phone
8
Associate Director, Operational ComplianceReveal Email/Phone
9
Chief Operating OfficerReveal Email/Phone
10
Executive DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$22.3M1118%N/AN/A
#2
$17.7M88-19%N/AN/A
#3
$6.6M33-8%N/AN/A
#4
$29.1M14548%N/AN/A
#5
$1.2M6-50%N/AN/A
#6
$2.2M1110%N/AN/A
#7
$4.8M24-17%N/AN/A
#8
$34.8M1735%N/AN/A
#9
$46.2M2305%N/AN/A
#10
$3.2M16-11%N/AN/A
Add Company

What Is Imaging Endpoints?

Imaging Endpoints (IE) is a mission driven research and imaging CRO with offices in Scottsdale, Arizona and Waltham, Massachusetts. We specialize in providing the industry's leading imaging expertise and most advanced technologies coupled with exquisite services. Our experience extends from translational to phase 3 trials and every step in-between. Our organization is unique in that it is owned by a team of over 40 in-house radiologists and nuclear medicine physicians that specialize in advanced imaging technologies. Our comprehensive services span all aspects of trial planning and conduct, including protocol development, site qualification and standardization, real-time image receipt/QC and reads, data management, regulatory compliance and preparation for meetings/submissions to regulatory authorities. Our Rapid Detection and Assessment of Response program (RaDAR) is designed to accelerate product development by integrating the most advanced imaging technologies into clinical trials. At Imaging Endpoints, our capabilities go above and beyond the typical imaging core lab offering. Learn more at www.imagingendpoints.com.

keywords:Biotechnology,Cleantech,Healthcare,Medical Diagnostics,Pharmaceuticals,Wind Power

N/A

Total Funding

230

Number of Employees

$46.2M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Imaging Endpoints News

2022-04-20 - Simultaneous CNV and Mutation Detection Method; AI ...

... CNV and Mutation Detection Method; AI-Enhanced Brain Imaging; More ... to explore new endpoints and ways to assess patient behavior,...

2022-04-06 - Edgewise-Funded Natural History Trial of Becker Muscular ...

... is designed to understand the disease progression of individuals with BMD as assessed by functional measures and imaging endpoints.

2022-03-30 - Imeka and GE Healthcare Collaborate to Advance Precision ...

"Our Advanced Neuro Imaging Endpoints (ANIE) biomarker platform is ... Imeka offers an ability to combine diffusion MRI imaging and AI to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M230-2%N/A
#2
$52.3M2333%N/A
#3
$62.8M233-5%N/A
#4
$54.3M2352%N/A
#5
$46.7M23620%N/A